Consolidated Statements of Changes in Equity - USD ($) $ in Thousands |
Share premium [member] |
Reverse Recapitalization Reserve [member] |
Merger reserve [member] |
Reserve of share-based payments [member] |
Statutory reserve [member] |
Capital reserve [member] |
Retained earnings [member] |
Reserve of exchange differences on translation [member] |
Equity attributable to owners of parent [member] |
Non-controlling interests [member] |
Total equity [member] |
---|---|---|---|---|---|---|---|---|---|---|---|
Balance at Dec. 31, 2021 | $ 111,960 | $ (79,596) | $ 9,257 | $ 20,034 | $ 21,238 | $ 9,614 | $ (87,465) | $ 2,439 | $ 7,481 | $ (202) | $ 7,279 |
IfrsStatementLineItems [Line Items] | |||||||||||
Net income (loss) for the period | (8,607) | (8,607) | 635 | (7,972) | |||||||
Exchange difference on transaction of financial statements of foreign operations | 29 | 29 | 29 | ||||||||
Total comprehensive loss for the period | (8,607) | 29 | (8,578) | 635 | (7,943) | ||||||
Issuance of new shares for equity financing | 851 | 851 | 851 | ||||||||
Additional paid in capital | 364 | 364 | |||||||||
Equity compensation - employee share-based compensation | 10 | 314 | 324 | 324 | |||||||
Balance at Dec. 31, 2022 | 112,821 | (79,596) | 9,257 | 20,348 | 21,238 | 9,614 | (96,072) | 2,468 | 78 | 797 | 875 |
IfrsStatementLineItems [Line Items] | |||||||||||
Net income (loss) for the period | (2,025) | (2,025) | (17) | (2,042) | |||||||
Exchange difference on transaction of financial statements of foreign operations | (260) | (260) | (260) | ||||||||
Total comprehensive loss for the period | (2,025) | (260) | (2,285) | (17) | (2,302) | ||||||
Issuance of new shares for equity financing | 8,323 | 8,323 | 8,323 | ||||||||
Equity compensation - employee share-based compensation | 104 | 6,881 | 6,985 | 6,985 | |||||||
Conversion of long-term notes into common shares | 520 | 520 | 520 | ||||||||
Balance at Dec. 31, 2023 | 121,768 | (79,596) | 9,257 | 27,229 | 21,238 | 9,614 | (98,097) | 2,208 | 13,621 | 780 | 14,401 |
IfrsStatementLineItems [Line Items] | |||||||||||
Net income (loss) for the period | (10,544) | (10,544) | (43) | (10,587) | |||||||
Exchange difference on transaction of financial statements of foreign operations | (348) | (348) | (49) | (397) | |||||||
Total comprehensive loss for the period | (10,544) | (348) | (10,892) | (92) | (10,984) | ||||||
Issuance of new shares for equity financing | 12,639 | 12,639 | 12,639 | ||||||||
Equity compensation - employee share-based compensation | 348 | 5,991 | 6,339 | 6,339 | |||||||
Conversion of long-term notes into common shares | 2,618 | 2,618 | 2,618 | ||||||||
Warrants exercised | 1,228 | 1,228 | 1,228 | ||||||||
Balance at Dec. 31, 2024 | $ 138,601 | $ (79,596) | $ 9,257 | $ 33,220 | $ 21,238 | $ 9,614 | $ (108,641) | $ 1,860 | $ 25,553 | $ 688 | $ 26,241 |